Keywords: palatin, ed, drug, achieves, trial, goals, usa

Palatin's ED drug achieves trial goals

Article | 10 November 2003

Print This

The USA's Palatin Technologies has released positive Phase IIb data forPT-141, its intranasal therapy for erectile dysfunction, at the 8th ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in